Prospective REgistry of Stable Angina manaGEment and Treatment (PRESAGE)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03781492|
Recruitment Status : Recruiting
First Posted : December 20, 2018
Last Update Posted : December 20, 2018
|Condition or disease|
|Stable Angina Coronary Artery Disease|
The Prospective REgistry of Stable Angina manaGEment and Treatment (PRESAGE) is a single-center, observational study recruiting consecutive patients with stable angina, who were diagnosed and treated in the 3rd Chair and Department of Cardiology in the Silesian Centre for Heart Diseases in Zabrze, Poland. The Silesian Centre for Heart Diseases is a highly specialised cardiology centre with cardiac surgery facilities
The main objective of the PRESAGE Registry is to clarify the overall clinical characteristics of patients with stable angina, their demographics and clinical profile, current management, early and long-term outcomes, with regard to the administered treatment.
The diagnosis of stable angina was based on clinical characterization, coronary angiography, and the current guidelines of the European Society of Cardiology. Patients with vasospastic and/or microvascular angina were also included to the registry. Performance of coronary angiography is the criterion of the enrolment in the registry.
Patients with acute coronary syndromes are excluded from the analysis.
Data collection is patient-based (not event-based).
Complete patient demographics: medical history, complete hospitalization data (diagnostic and therapeutic) and in-hospital results are collected in an electronic form by the attending physician. The patients are under constant follow-up for all-cause mortality and major cardiac adverse events.
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||25000 participants|
|Target Follow-Up Duration:||5 Years|
|Official Title:||Prospective REgistry of Stable Angina manaGEment and Treatment|
|Actual Study Start Date :||January 1, 2006|
|Estimated Primary Completion Date :||December 31, 2026|
|Estimated Study Completion Date :||December 31, 2026|
- Number of participants with reported deaths from any cause [ Time Frame: From date of inclusion until the date of death from any cause, assessed up to 5 year ]
- Number of participants with reported myocardial infarction [ Time Frame: From date of inclusion until the date of first event, assessed up to 5 year ]
- Number of participants with reported cerebrovascular insult [ Time Frame: From date of inclusion until the date of first event, assessed up to 5 year ]
- Number of participants with reported acute coronary syndrome driven revascularisation [ Time Frame: From date of inclusion until the date of first event, assessed up to 5 year ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03781492
|Contact: Piotr Desperak, MDemail@example.com|
|3rd Chair and Department of Cardiology of Silesian Centre for Heart Diseases||Recruiting|
|Zabrze, Silesia, Poland, 41-800|
|Contact: Mariusz Gąsior, Prof, MD, PhD|